| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |